BCM
TARO

Bayesian Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bayesian Capital Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,900
Closed -$726K – 740
2016
Q4 		$726K Buy
+6,900
New +$723K 0.18% 210

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Bayesian Capital Management's TARO Position: Q1 2017 in Review

Bayesian Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 6,900 shares — an estimated $726K sold.

Bayesian Capital Management first reported a position in TARO in Q4 2016 and held it in 1 quarter. The position peaked at $726K in Q4 2016. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

  • Bayesian Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 6,900 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $726K.
  • Bayesian Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 1 quarter.
  • Bayesian Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $726K in Q4 2016.
  • 139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.